Dr. Jamal A. Khan is a pioneer in cancer immunotherapy in India, with over seven years of exclusive clinical experience in dendritic cell therapy. His work on dendritic cell therapy in treating cancer is unparalleled in India. Dr. Jamal A. Khan has been a researcher and teaching faculty at the Jawaharlal Nehru Medical College at Aligarh Muslim University, from 1997 till 2005.
Voices Against Brain Cancer is an organization that has been serving with a motive of raising voice against such a serious cause. Our mission is to find Brain Cancer Cure and help those suffering from the same.
NET Research Foundation receives $15 million gift from the Margie and Robert E. Petersen Foundation to fund ambitious research effort to find cure for rare cancer affecting over 100,000 Americans.
H2Biologics gets exclusive rights for human granzyme B (GrB) to develop immunoconjugate with a human single domain antibody (SD1) that targets mesothelin-expressing tumors.
Hope for the Holidays Toy Drive at the Oncology Institute of Hope and Innovation benefitting family members of patients and the Children's Hospital of Orange County (CHOC).
The Oncology Institute Clinical Trials - The Oncology Institute Hit a Milestone of Opening 160 Clinical Trials and Enrolling 1,000 Patients in 8 Years.
The Caring for Carcinoid Foundation, a nonprofit organization that funds research to discover cures for neuroendocrine cancers, has changed its name to the Neuroendocrine Tumor Research Foundation, and launched a new brand and website.
The 2015 International Radon Symposium took place September 20-23. SWAT Environmental along with the international radon community joined forces to promote future growth and awareness in the field of radon mitigation.
Breast Cancer Foundation ("BCF") has named Brand Incorporated ("Brand Inc.") as its digital public relations partner for Pink Ribbon Walk 2015 ("PRW").
Celebration of Life: A cancer Anthology has been launched on Kickstarter, raising the funds to print a comic anthology telling the inspiring stories of those affected by cancer, and in turn raising funds from the sale of the book to help beat cancer once and for all.
January is National Radon Action Month. Approximately 21,000 Americans lives are claimed each year from lung cancer due to radon. One in 15 homes contains high levels of radon. The American Lung Association, Centers for Disease Control and National Cancer Institute are in agreement that radon is a worldwide health problem and encourage radon testing during the "National Radon Action Month".
After a year of reviewing the research, consulting with experts, and engaging leading immunotherapy centers, the Caring for Carcinoid Foundation is thrilled to announce the launch of a major immunotherapy initiative for neuroendocrine cancer. A treatment that uses the body's own immune system to fight cancer, immunotherapy has led to dramatic results for some patients with other forms of cancer.
India's first oncology nutrition conference was hosted and organized by Indore Regional Centre of The Society for Clinical Nutrition and Metabolism (IAPEN) on 9th November, 2014 at Choithram Hospital and Research Centre, Indore, Madhya Pradesh, India.
October 20th - 26th, 2014 has been designated as National Radon Action Week in The United States. Health agencies throughout the country have joined forces to promote awareness of this household Class A Carcinogen. S.W.A.T. Environmental is North America's largest radon testing and radon mitigation company and is participating in the October awareness drive by offering 1,000 radon testing kits.
WICR Waterproofing & Decking announced today that they joined the Community Association Institute Greater Los Angeles Chapter (Team CAI-GLAC) in the effort to end cancer once and for all by participating in the American Cancer Society Relay for Life. This inspiring fundraising event will be held at the Santa Monica College in the Los Angeles area on Saturday, July 26, 2014.
Presented at ASCO data on the first set of patients from the pivotal Phase III TK008 study: the survival benefit exceeds trial target in acute leukaemia patients.
A new study indicates a higher risk associated with radon in Portland Oregon. It shows one in four Portland homes have radon levels above the recommended EPA action level.
Satisfied Users & 
Approved Press Releases
